Nalaganje...
HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
BACKGROUND: European guidelines for cervical cancer screening now recommend the use of clinically validated assays for high-risk HPV-DNA sequences as primary test in women older than 30 years, performed in centralized laboratories, and run on systems providing automated solutions for all steps. METH...
Shranjeno v:
| izdano v: | BMC Womens Health |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6434866/ https://ncbi.nlm.nih.gov/pubmed/30909894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12905-019-0743-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|